BREAKTHROUGHS BLOG

February 21, 2014

Research Roundup: What we’re reading this week

Senior Program Assistant
GHTC

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

A new report sponsored by the Bill & Melinda Gates Foundation examines the need for post-market surveillance for new drugs and vaccines in low- and middle-income countries. The report is based off the findings from the Safety Surveillance Working Group, and provides recommendations stakeholders should take to strengthen post-market surveillance of global health products.

The University of South Florida’s Center for Drug Development and Innovation, and the College of Public Health’s Department of Global Health have been awarded a grant of $2.1 million from the National Institutes of Health. The focus of the research will be to see how parasites, like malaria, grow.

At a recent event in Washington, DC, US Agency for International Development (USAID) Administrator Rajiv Shah underscored the agency’s commitment to public-private partnerships. According to Devex, 40 percent of USAID’s resources are programmed through public-private partnerships.

New studies show that patients with multidrug-resistant tuberculosis (TB) and HIV/AIDS have a higher chance of living if they take simultaneous treatment for both diseases, as oppose to waiting to take HIV/AIDS treatment. The initial study was small in size, but concurs with three previous major studies of people with regular TB and HIV/AIDS.

back